# Suppression Of Bacterial Vaginosis (BV) [SUBVert]

> **NCT03930745** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 81 (actual)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **OTHER:** Placebo
- **DRUG:** TOL-463

## Key facts

- **NCT ID:** NCT03930745
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-09
- **Primary completion:** 2021-12-06
- **Final completion:** 2021-12-06
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03930745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03930745, "Suppression Of Bacterial Vaginosis (BV) [SUBVert]". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03930745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*